cell
clone
confirm
delet
occur
final
show
first
time
escap
prevent
four
differ
shrna
simultan
express
olivi
ter
brake
karen
hooft
ying
poi
liu
human
immunodefici
viru
type
replic
cell
inhibit
rna
interfer
rnai
short
hairpin
rna
shrna
express
lentivir
vector
howev
develop
durabl
rnaibas
gene
therapi
multipl
shrna
need
express
simultan
order
avoid
viral
escap
studi
test
multipl
shrna
express
strategi
differ
shrna
use
repeat
promot
lentivir
vector
although
highli
effect
cotransfect
experi
markedli
reduc
activ
express
shrna
observ
transduc
cell
found
reduc
activ
due
recombin
express
cassett
repeat
sequenc
transduct
lentivir
vector
result
delet
one
multipl
cassett
avoid
recombin
test
differ
promot
multipl
shrna
express
compar
activ
human
polymeras
iii
promot
polymeras
ii
promot
activ
promot
similar
irrespect
shrna
express
show
four
express
cassett
combin
singl
lentivir
vector
without
caus
recombin
moreov
wherea
could
escap
singl
shrna
show
escap
prevent
four
shrna
simultan
express
cell
rna
interfer
rnai
transient
transfect
small
interf
rna
sirna
highli
effect
wide
rang
virus
instanc
human
immunodefici
viru
type
hepat
b
viru
hepat
c
viru
influenza
viru
sever
coronavirus
phase
clinic
trial
alreadi
perform
respiratori
syncyti
viru
infect
nasal
administ
sirna
howev
constant
suppli
sirna
requir
develop
rnaibas
therapi
chronic
viral
infect
like
eleg
way
achiev
object
use
gene
therapi
approach
antivir
sirna
stabli
express
cell
short
hairpin
rna
shrna
stabl
express
antihiv
shrna
cell
result
potent
inhibit
replic
howev
applic
singl
shrna
inhibitor
suffici
maintain
inhibit
extend
cultur
resist
viru
emerg
contain
point
mutat
delet
within
sirna
target
site
thu
order
achiev
durabl
inhibit
multipl
antivir
sirna
express
simultan
strategi
similar
current
drug
combin
therapi
individu
strategi
express
multipl
sirna
includ
extend
shrna
long
doublestrand
rna
express
multipl
shrna
express
latter
current
promis
lentivir
vector
system
highli
effect
deliveri
shrna
express
cassett
appar
straightforward
method
express
multipl
shrna
lentivir
vector
incorpor
multipl
express
cassett
use
promot
howev
approach
may
problemat
due
intrins
properti
lentivir
vector
retrovirus
natur
recombin
prone
revers
transcriptas
polymeras
poor
process
transduct
process
revers
transcriptas
convert
rna
genom
dna
revers
transcriptas
slip
repeat
rna
templat
result
sequenc
duplic
delet
could
serious
hamper
genet
stabil
lentivir
vector
multipl
shrna
cassett
construct
singl
doubl
tripl
antihiv
shrna
lentivir
vector
express
shrna
repeat
promot
initi
cotransfect
experi
indic
multipl
shrna
express
strategi
effect
individu
shrna
activ
compar
singl
multipl
shrna
construct
howev
strikingli
differ
pattern
emerg
transduc
cell
sinc
shrna
activ
diminish
increas
number
shrna
cassett
analyz
cell
clone
transduc
multipl
shrna
lentivir
vector
found
recombin
occur
frequent
instanc
cell
clone
transduc
tripl
shrna
lentiviru
contain
intact
proviru
thu
reduc
shrna
activ
caus
recombinationmedi
delet
shrna
cassett
order
prevent
recombin
design
viral
vector
without
repeat
sequenc
four
differ
shrna
express
four
differ
promot
analyz
transduc
screen
shrna
target
highli
conserv
sequenc
identifi
multipl
potent
inhibitor
valid
sequenc
specif
luciferas
report
figur
develop
multipl
shrna
approach
construct
plasmid
encod
two
three
differ
shrna
express
promot
figur
construct
encod
inhibitor
encod
addit
use
appropri
luciferas
report
measur
activ
individu
shrna
initi
cotransfect
experi
report
shrna
target
cotransfect
plasmid
measur
specif
report
gene
knockdown
irrespect
type
vector
use
instanc
inhibit
score
luc
report
show
equal
activ
figur
sever
control
vector
includ
empti
lentivir
vector
sever
unrel
shrna
impact
luc
report
similar
result
obtain
shrna
multishrna
vector
match
report
data
shown
next
transduc
cell
lentivir
vector
low
multipl
infect
moi
obtain
singl
lentivir
vector
copi
per
cell
transduc
green
fluoresc
protein
gfp
posit
cell
select
live
fluorescenceactiv
cell
sort
fac
transfect
cell
luc
report
observ
good
inhibit
profound
decreas
magnitud
inhibit
figur
similar
drop
activ
score
shrna
encod
construct
respect
target
data
shown
thu
strike
differ
observ
transient
transfect
cell
versu
stabli
transduc
cell
line
wherea
full
activ
shrna
observ
former
assay
inhibitori
potenti
significantli
reduc
transduc
cell
one
could
argu
due
satur
rnai
pathway
highli
unlik
transduc
cell
singl
lentivir
vector
copi
anoth
possibl
shrna
cassett
effect
transduc
eg
recombinationmedi
delet
due
repeat
sequenc
express
cassett
figur
repeat
sequenc
present
tripl
cassett
insert
constitut
promot
nucleotid
nt
sequenc
encod
pol
iii
termin
nt
figur
test
intact
integr
proviru
select
cell
clone
transduc
cell
amplifi
shrna
insert
polymeras
chain
reaction
pcr
primer
figur
analyz
clone
control
untransduc
cell
clone
includ
input
plasmid
strikingli
observ
band
cell
clone
differ
among
differ
clone
discret
size
correspond
either
singl
doubl
tripl
cassett
figur
minor
cell
clone
seem
intact
tripl
cassett
cultur
wherea
observ
appar
doubl
singl
sequenc
pcr
product
analyz
actual
recombin
event
summar
figur
look
singlecassett
delet
cassett
b
frequent
delet
clone
cassett
c
delet
twice
respect
doublecassett
delet
mutant
ab
bc
delet
observ
provirus
observ
c
delet
probabl
requir
doubl
recombin
event
delet
three
cassett
possibl
repeatinduc
recombin
inde
observ
delet
c
requir
recombin
promot
delet
possibl
recombin
termin
sequenc
total
delet
seen
less
frequent
delet
c
indic
recombin
promot
like
would
expect
sinc
repres
largest
repeat
sequenc
delet
b
occur
often
clone
analyz
also
observ
delet
cell
clone
transduc
lentivir
vector
data
shown
sinc
delet
express
cassett
frequent
observ
cell
clone
result
explain
magnitud
inhibit
reduc
shrna
cell
transduc
delet
also
seen
transduc
tcell
line
cell
clone
contain
intact
doubl
tripl
cassett
respect
thu
repeat
sequenc
avoid
effect
multipl
shrna
express
lentivir
vector
order
prevent
recombin
test
four
differ
promot
shrna
express
figur
human
polymeras
iii
promot
human
polymeras
ii
promot
genet
element
homolog
sequenc
select
transcript
start
termin
site
well
defin
thu
produc
discret
shrnainhibitor
molecul
promot
made
five
differ
shrna
express
construct
nef
sequenc
figur
cotransfect
experi
compar
activ
express
cassett
appropri
report
figur
promoterreport
combin
use
correspond
shnef
construct
control
activ
set
shrna
made
four
promot
similarli
reduc
express
luc
report
top
left
panel
figur
similar
result
obtain
three
hairpin
combin
respect
report
sinc
luciferas
knockdown
similar
combin
shrna
promot
made
arbitrari
select
four
promotershrna
combinatori
approach
combin
made
cassett
figur
first
confirm
sirna
express
detect
sirna
northern
blot
sirna
express
construct
albeit
somewhat
reduc
compar
correspond
singl
shrnaexpress
vector
figur
may
caus
transfect
rel
high
amount
vector
construct
may
restrict
optim
shrna
process
limit
cellular
compon
rnai
machineri
quantit
set
avoid
competit
effect
transfect
low
amount
vector
construct
ng
test
construct
cotransfect
four
luciferas
report
figur
control
cell
receiv
shrna
inhibitor
ctrl
activ
set
construct
activ
four
report
fact
inhibitori
potenti
similar
appropri
singl
shrna
construct
result
confirm
multipl
shrna
effici
express
singl
construct
use
differ
promot
insert
express
cassett
figur
lentivir
vector
figur
produc
lentivir
vector
transduc
cell
low
moi
select
gfpposit
cell
live
fac
first
select
transduc
cell
clone
check
statu
integr
proviru
perform
pcr
across
insert
observ
band
correspond
size
cassett
figur
control
lane
c
show
pcr
input
plasmid
twocel
clone
either
untransduc
transduc
cell
also
shown
control
thu
cassett
four
differ
promot
stabli
transduc
second
compar
luciferas
report
inhibit
transduc
cell
previous
construct
singl
shrna
cell
line
figur
note
cell
line
express
indic
shrna
promot
report
inhibit
cell
similar
magnitud
shrna
fulli
specif
match
report
cell
inhibit
observ
four
report
quantit
similar
level
report
inhibit
observ
express
polymeras
ii
promot
reduc
magnitud
inhibit
compar
shrna
coincid
reduc
express
level
figur
combin
data
show
recombin
prevent
use
differ
promot
drive
shrna
express
four
differ
shrna
simultan
express
singl
lentivir
vector
test
effect
multipl
shrna
express
replic
stabli
transduc
tcell
line
fulli
suscept
replic
lai
isol
produc
lentivir
vector
codonoptim
gagpol
packag
construct
avoid
target
viral
sequenc
vector
system
result
reduc
vector
titer
titer
vector
reduc
compar
vector
tabl
like
due
insert
rel
larg
quadrupl
cassett
nt
increas
vector
genom
size
known
neg
effect
titer
concentr
lentivir
vector
stock
similar
titer
use
transduc
cell
low
moi
transduc
cell
select
fac
gfpexpress
cell
line
viabl
differ
growth
rate
observ
infect
six
independ
cultur
cell
line
lai
isol
effici
replic
viru
measur
control
vectortransduc
cell
figur
viru
replic
initi
potent
inhibit
cell
figur
howev
extend
cultur
replic
viru
emerg
five
six
cultur
judg
increas
cultur
medium
syncytia
format
test
put
escap
viru
infect
set
cell
viru
inde
show
resist
phenotyp
replic
control
cell
cell
cell
express
anoth
shrna
inhibitor
combin
figur
sequenc
analysi
confirm
resist
point
mutat
within
target
sequenc
five
escap
cultur
observ
simultan
test
replic
cell
line
prolong
inhibit
replic
observ
day
four
six
cultur
figur
inhibit
viru
replic
initi
potent
howev
slowli
replic
viru
emerg
two
cultur
day
virus
could
repres
escap
virus
perhap
still
partial
inhibit
slowli
replic
due
mutat
multipl
highli
conserv
sequenc
result
loss
viral
fit
altern
slow
spread
input
wildtyp
viru
may
occur
block
complet
other
describ
pseudoescap
phenomenon
cell
line
allow
effici
viral
spread
via
cellcel
contact
critic
discrimin
possibl
passag
accumul
viru
set
uninfect
cell
viru
abl
replic
control
cell
shrnaexpress
cell
either
singl
inhibitor
figur
result
indic
breakthrough
viru
resist
abbrevi
shrna
short
hairpin
rna
four
shrna
express
cell
line
import
conclus
confirm
sequenc
four
target
sequenc
viral
genom
singl
point
mutat
observ
four
target
cell
constitut
major
cell
popul
implic
infect
make
cell
resist
key
aspect
antihiv
gene
therapi
thu
also
test
lentivir
vector
transduc
primari
cell
cell
transduc
low
moi
control
vector
vector
vector
transduc
cell
select
transduc
cell
line
differ
viabil
growth
rate
observ
next
challeng
transduc
cell
wildtyp
viru
figur
control
cell
effici
viru
replic
detect
contrast
viru
replic
strongli
inhibit
cell
potent
inhibit
score
latter
cell
also
infect
transduc
cell
mutant
resist
due
g
mutat
target
posit
figur
mutant
viru
replic
equal
well
control
cell
confirm
resist
strongli
inhibit
cell
line
wildtyp
viru
result
show
combin
action
four
shrna
result
potent
inhibit
compar
singl
shrna
primari
cell
develop
effect
rnaibas
gene
therapi
simultan
express
multipl
shrna
requir
avoid
viral
escap
rel
simpl
strategi
would
express
shrna
separ
promot
sever
group
report
express
multipl
rna
separ
promot
lentivir
vector
perform
indepth
analysi
multipl
shrna
express
strategi
three
shrna
express
repeat
promot
found
express
strategi
caus
frequent
recombin
within
lentivir
vector
genom
repeat
sequenc
express
cassett
result
delet
one
two
cassett
thu
cell
transduc
lentivir
vector
result
heterogen
popul
integr
lentiviru
provir
dna
express
one
two
three
shrna
develop
success
rnaibas
gene
therapi
approach
multipl
shrna
express
strategi
unlik
success
cell
popul
express
singl
shrna
provid
nich
resist
virus
select
ultim
lead
full
resist
shrna
order
prevent
recombin
select
four
differ
promot
lack
sequenc
similar
multipl
shrna
express
strategi
human
polymeras
iii
promot
human
polymeras
ii
promot
select
well
defin
transcript
start
termin
site
differ
inhibitori
activ
therefor
reflect
differ
express
level
activ
promot
compar
subset
two
promot
test
compar
four
promot
measur
similar
shrna
inhibitori
activ
promot
also
combin
construct
express
cassett
activ
confirm
multipl
shrna
express
four
promot
valid
approach
construct
lentivir
vector
design
analysi
transduc
cell
clone
indic
vector
recombin
vector
titer
reduc
due
increas
vector
genom
size
note
pgk
promot
gfp
gene
nt
eventu
remov
clinic
vector
thu
avoid
product
problem
next
test
effect
replic
gene
therapi
set
transduc
cell
line
express
singl
shrna
could
escap
mutat
target
sequenc
contrast
escap
cell
line
howev
viral
spread
observ
two
six
infect
cell
cultur
though
virus
true
escap
mutant
sinc
resist
phenotyp
upon
viral
passag
fresh
cell
furthermor
genotyp
chang
observ
four
target
sequenc
result
indic
viru
replic
complet
block
combin
express
four
shrna
come
surpris
sinc
rnai
target
incom
genom
rnai
silenc
gene
express
complet
thu
viru
replic
may
still
occur
albeit
low
level
perhap
slowli
accumul
certain
threshold
reach
product
measur
importantli
wit
viral
escap
show
impos
genet
barrier
high
viru
overcom
inhibit
four
shrna
difficult
assess
implic
result
gene
therapi
cell
blood
stem
cell
patient
treat
ex
vivo
singl
lentivir
vector
copi
per
cell
obtain
durabl
inhibit
day
vector
addit
also
observ
primari
cell
transduc
lentiviru
viabl
normal
growth
rate
shown
wildtyp
viru
potent
inhibit
cell
next
step
evalu
therapeut
potenti
vector
test
relev
vivo
system
recent
mous
model
human
immun
system
develop
propos
use
purpos
studi
safeti
vector
analyz
develop
immun
system
transduc
human
precursor
cell
addit
also
infect
mice
evalu
vivo
efficaci
durabl
multipl
shrna
approach
gene
therapi
protect
cell
hold
great
promis
treatment
individu
recent
first
phase
clinic
trial
involv
lentivir
vector
shown
safe
clinic
trial
patient
treat
condit
replic
viral
vector
encod
antisens
sequenc
direct
genom
year
clinic
trial
expect
start
combin
differ
antihiv
rna
singl
lentivir
vector
promis
result
present
strongli
support
develop
multipl
shrna
strategi
shown
safe
effect
vivo
may
next
line
clinic
test
plasmid
construct
prrlcpptpgkgfppressin
singl
doubl
tripl
shrna
lentivir
vector
previous
describ
construct
use
shrna
express
base
psuper
oligoengin
seattl
wa
psilenc
ambion
austin
tx
invivogen
san
diego
ca
pgeneclipbasicvector
promega
madison
wi
contain
human
polymeras
iii
promot
human
polymeras
ii
promot
respect
renam
first
shrna
express
plasmid
construct
insert
anneal
oligonucleotid
encod
shrna
transcript
appropri
insert
site
oligonucleotid
design
addit
restrict
site
ad
transcript
termin
site
construct
facilit
clone
construct
bglii
zrai
clai
xhoi
sali
xhoi
plasmid
construct
differ
shrna
express
plasmid
follow
first
cassett
insert
behind
cassett
claisali
restrict
site
second
cassett
excis
ecoribglii
insert
front
promot
use
ecoribamhi
site
final
doubl
cassett
insert
salixhoi
site
construct
yield
cassett
excis
smaixhoi
insert
lentivir
vector
backbon
multipl
clone
site
ecorvxhoi
result
cell
cultur
human
embryon
kidney
adher
cell
grown
dulbecco
modifi
eagl
medium
invitrogen
carlsbad
ca
supplement
fetal
calf
serum
penicillin
uml
streptomycin
suspens
cell
grown
advand
rosewel
park
memori
institut
medium
invitrogen
carlsbad
ca
supplement
lglutamin
fetal
calf
serum
penicillin
uml
streptomycin
humidifi
chamber
co
peripher
blood
mononuclear
cell
grown
rosewel
park
memori
institut
medium
invitrogen
carlsbad
ca
supplement
fetal
calf
serum
penicillin
um
streptomycin
stimul
uml
phytohemagglutinin
day
cell
deplet
cell
subsequ
cultur
without
phytohemagglutinin
lentivir
vector
product
lentivir
vector
produc
previous
describ
briefli
vector
produc
cotransfect
lentivir
vector
plasmid
packag
plasmid
psyngp
prsvrev
pvsvg
lipofectamin
invitrogen
carlsbad
ca
transfect
medium
replac
optimem
invitrogen
carlsbad
ca
lentivir
vector
contain
supernat
collect
filter
concentr
use
amicon
ultra
concentr
mwco
millipor
bedford
aliquot
store
lentivir
vector
stock
titrat
cell
cell
primari
cell
cell
cell
transduc
indic
moi
peripher
blood
mononuclear
cell
transduc
deplet
two
three
day
transduct
live
cell
sort
fac
gfpposit
cell
select
select
transduc
cell
clone
singl
gfpposit
cell
select
fac
transfect
experi
cotransfect
firefli
luciferas
report
shrnaexpress
plasmid
transfect
firefli
luciferas
report
stabl
cell
line
perform
previous
describ
intern
control
renilla
luciferas
prl
briefli
ng
firefli
report
cotransfect
ng
figur
ng
figur
psuper
singl
shrna
construct
equimolar
quantiti
construct
ng
intern
control
prl
format
firefli
renilla
luciferas
activ
measur
dualluciferas
report
assay
system
promega
madison
wi
lai
resist
viru
produc
transfect
cell
viru
product
measur
enzymelink
immunosorb
assay
cell
cultur
cell
infect
ng
transduc
cell
ml
cell
infect
ng
viru
spread
monitor
measur
product
pcr
sequenc
cellular
dna
extract
cell
clone
cell
qiagen
dnaeasi
kit
qiagen
valencia
ca
pcr
perform
across
multipl
clone
site
primer
pair
agtgaacggatctcgacggtat
tagtaacggccgcc
agtgtgct
cycl
denatur
second
anneal
extens
pcr
product
use
standard
direct
sequenc
big
dye
termin
cycl
sequenc
kit
abi
foster
citi
ca
use
primer
moll
betain
ad
sequenc
reaction
sirna
detect
northern
blot
transfect
human
embryon
kidney
cell
plate
plate
densiti
cell
per
well
ml
dulbecco
modifi
eagl
medium
fetal
calf
serum
without
antibiot
next
day
equimolar
quantiti
shrna
construct
transfect
eg
psuper
use
lipofectamin
total
rna
purifi
use
mirvana
mirna
isol
kit
ambion
austin
tx
northern
blot
analysi
total
rna
heat
minut
electrophores
denatur
polyacrylamid
gel
precast
novex
tbu
gel
invitrogen
carlsbad
ca
check
equal
load
gel
stain
ethidium
bromid
ultrapur
water
minut
destain
perform
rins
gel
three
time
ultrapur
water
minut
band
visual
ultraviolet
light
rna
gel
electrotransf
posit
charg
nylon
membran
boehring
mannheim
gmbh
mannheim
germani
rna
crosslink
membran
use
ultraviolet
light
wavelength
nm
lock
nucleic
acid
oligonucleotid
end
label
kinasemax
kit
ambion
austin
tx
presenc
p
atp
amersham
bioscienc
piscataway
nj
use
probe
use
follow
lock
nucleic
acid
oligonucleotid
sirna
rt
sirna
pol
sirna
gag
gtgaagg
sirna
pol
underlin
posit
contain
lock
nucleic
acid
remov
unincorpor
label
nucleotid
probe
purifi
use
sephadex
spin
column
amersham
bioscienc
piscataway
nj
accord
manufactur
protocol
situ
hybrid
perform
label
lock
nucleic
acid
oligonucleotid
ml
ultrahyb
hybrid
buffer
ambion
austin
tx
accord
manufactur
instruct
hybrid
membran
wash
twice
minut
moll
sodium
chlorid
sodium
citrat
ph
sodium
dodecyl
sulfat
minut
moll
sodium
chlorid
sodium
citrat
ph
sodium
dodecyl
sulfat
signal
detect
autoradiographi
use
phosphorimag
